AGXStarseed
Well-Known Member
(Not written by me)
Scientists trial ground-breaking nasal spray treatment for disorder that could be on shelves in as little as five years
Trials for drug that allows individuals with autism to become more social showing incredible results
The treatment, a synthetic version of “cuddle hormone” oxytocin, allows individuals living with autism to become more social and has exhibited incredible results in trials so far.
Speaking on the project, professor Adam Guastella, of the University of Sydney’s Brain and Mind Centre, said trials have been extremely promising so far.
In an interview with Australia’s 9 News, professor Guastella said: “The sorts of results that we have in our trials suggest children show more responsiveness and awareness of the important social information in a relationship.”
He continued: “They seem to be able to remember that information more effectively.”
Autism spectrum disorder and autism are general terms for a complex group of disorders that influence brain development.
The mental condition is characterised with varying degrees of difficulties in social interaction.
Christine Blue, whose son Hayden was diagnosed with autism aged just two, told of his experiences in the trial.
She told 9 News: “Hayden was happy to be included in a group, he wouldn't go off on his own and his eye contact was better.
“His general engagement with another person is better,” she added.
It is hoped the new treatment will also be able to treat anxiety and other neurological conditions in the near future.
If all goes to plan, the drug could be commercially available for individuals with autism within the next five years.
According to the National Autistic Society, there are approximately 700,000 people in the UK living with autism, which equates to more than one in 100.
SOURCE: https://www.thesun.co.uk/news/16062...uld-be-on-shelves-in-as-little-as-five-years/
Scientists trial ground-breaking nasal spray treatment for disorder that could be on shelves in as little as five years
Trials for drug that allows individuals with autism to become more social showing incredible results
The treatment, a synthetic version of “cuddle hormone” oxytocin, allows individuals living with autism to become more social and has exhibited incredible results in trials so far.
Speaking on the project, professor Adam Guastella, of the University of Sydney’s Brain and Mind Centre, said trials have been extremely promising so far.
In an interview with Australia’s 9 News, professor Guastella said: “The sorts of results that we have in our trials suggest children show more responsiveness and awareness of the important social information in a relationship.”
He continued: “They seem to be able to remember that information more effectively.”
Autism spectrum disorder and autism are general terms for a complex group of disorders that influence brain development.
The mental condition is characterised with varying degrees of difficulties in social interaction.
Christine Blue, whose son Hayden was diagnosed with autism aged just two, told of his experiences in the trial.
She told 9 News: “Hayden was happy to be included in a group, he wouldn't go off on his own and his eye contact was better.
“His general engagement with another person is better,” she added.
It is hoped the new treatment will also be able to treat anxiety and other neurological conditions in the near future.
If all goes to plan, the drug could be commercially available for individuals with autism within the next five years.
According to the National Autistic Society, there are approximately 700,000 people in the UK living with autism, which equates to more than one in 100.
SOURCE: https://www.thesun.co.uk/news/16062...uld-be-on-shelves-in-as-little-as-five-years/
